Pharmacology · Cardiovascular Drugs (Antihypertensives, Anti-Anginals, Heart Failure, Anti-Arrhythmics)

Sacubitril/valsartan (ARNI) is approved for heart failure with reduced ejection fraction (HFrEF). What is the critical washout period required between ACE inhibitor discontinuation and starting sacubitril/valsartan, and why?

  • A 24 hours; to prevent first-dose hypotension
  • B 36 hours (≥5 half-lives); to prevent angioedema from dual neprilysin and ACE inhibition potentiating bradykinin accumulation
  • C 36 hours; to allow complete renal clearance of the ACE inhibitor
  • D 7 days; to allow cardiac remodeling reversal from the ACE inhibitor
Correct answer: B. 36 hours (≥5 half-lives); to prevent angioedema from dual neprilysin and ACE inhibition potentiating bradykinin accumulation

Explanation

Sacubitril inhibits neprilysin (neutral endopeptidase), which degrades bradykinin. ACE inhibitors also prevent bradykinin degradation (by blocking kininase II/ACE). Concurrent use doubles bradykinin accumulation, causing life-threatening angioedema — particularly affecting the airway. A mandatory washout of ≥36 hours (equivalent to 5 half-lives of most ACEIs) between ACEI discontinuation and ARNI initiation is required per guidelines. This is one of the most tested clinical precautions for this drug class.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Cardiovascular Drugs (Antihypertensives, Anti-Anginals, Heart Failure, Anti-Arrhythmics) MCQs

See all Cardiovascular Drugs (Antihypertensives, Anti-Anginals, Heart Failure, Anti-Arrhythmics) MCQs →